Fortive accelerates growth as tariff fears finally fade away
- Fortive continues to operate as a more focused company after spinning off Precision Technologies in 2025.
- Q2 2026 core revenue grew 6.7%, driven by solid gains in both volume and pricing.
- Management raised full-year core growth expectations to roughly 4%, dissolving prior fears of a top-line slowdown.
- Tariff impacts faded, but a product mix shift lowered adjusted gross margin by about 100 basis points.
- Finn's overall score remains moderate, noting the need for sustained margin improvements alongside the top-line growth.
Growth accelerates while new margin risks emerge
Fortive has moved past the worst of its post-spin reset and prior tariff concerns. In Q2 2026, core revenue grew 6.7%, a notable acceleration from Q1. This growth was broad-based, fueled by a 4.3% increase in volume and a 2.4% boost in pricing. The performance prompted management to raise full-year core growth expectations to roughly 4% and adjust EPS guidance upward.
The bull case is currently accelerating. Fortive delivered its fourth consecutive quarter of double-digit adjusted EPS growth, up 28% year over year. Accelerated innovation, like Fluke's new data center tools and AI-enabled predictive maintenance software, is driving durable share gains. The prior bear case focused on tariff pressure is largely dead, as tariffs had a minimal impact during the quarter.
However, a new bear case has quickly formed around gross margins. A shift in product mix toward lower-margin offerings caused adjusted gross margin to contract by about 100 basis points year over year in Q2. Strong growth in ServiceChannel and ASP capital equipment drove this contraction. If this mix dynamic persists, it could offset the operational leverage Fortive is trying to build.
The next key milestones involve executing through the second half of the year. The company expects to realize additional tariff refunds soon, but faces a known 150-basis-point headwind to core growth in Q4 due to fewer selling days. Fortive is clearly growing faster, but investors will watch to see if margins can catch up.
Workflow tools with repeat demand
Fortive makes tools, software, and services used in jobs where errors are costly. Its products help factories test equipment, utilities manage assets, hospitals track instruments, and safety teams monitor workers. Customers often keep using these systems because they sit inside daily operations.
The company operates through two segments. Intelligent Operating Solutions sells test tools, facility and asset software, and connected safety products. Advanced Healthcare Solutions sells sterilization, tracking, biomedical testing, radiation detection, and clinical productivity tools. Fortive recently expanded its healthcare portfolio by acquiring a majority stake in UV Smart, adding specialized disinfection technology.
Money comes from a mix of equipment sales, software subscriptions, services, and recurring workflow use. That mix supports steady cash flow, allowing Fortive to fund both debt reduction and targeted acquisitions.
The model faces stress if customers delay projects, hospital budgets tighten, or lower-margin product sales outpace high-margin software. Fortive also has to manage post-separation liabilities tied to its former Precision Technologies unit, now called Ralliant.
What Fortive sells
Electrical test and measurement tools
These tools help technicians test electrical systems and equipment. They are used in factories, utilities, and service work where reliability matters.
Facility and asset lifecycle software
This software helps customers track buildings, equipment, maintenance, and compliance work. Growth here has been strong, though the product mix can impact margins.
Connected worker safety solutions
These products help monitor worker safety in industrial and field settings. Demand is tied to safety rules and the need to avoid costly incidents.
Sterilization and instrument tracking
Hospitals use these systems to clean, track, and manage medical instruments. Capital equipment sales in this category have recently accelerated.
Biomedical test and radiation detection tools
These tools help healthcare providers test medical equipment and detect radiation exposure. They serve regulated workflows with a low tolerance for mistakes.
Clinical productivity software
This software helps healthcare teams manage work more efficiently. It could become a larger growth driver if hospitals keep spending on productivity tools.
Two main engines now
The mix uses Q2 2026 sales: about $758 million from Intelligent Operating Solutions and $339 million from Advanced Healthcare Solutions.
What could break the momentum
Product mix drags down gross margins
High impact · Medium oddsA shift toward lower-margin products, specifically in ServiceChannel and ASP capital equipment, caused a 100-basis-point drop in adjusted gross margin during Q2 2026. If this sales mix becomes permanent, it will pressure profitability even if top-line revenue grows.
Calendar headwinds in the fourth quarter
Medium impact · High oddsManagement has flagged a known 150-basis-point headwind to core growth in Q4 2026 due to four fewer selling days. While anticipated, this mathematical drag could spook investors if underlying order growth also softens.
Post-spin costs and Ralliant liabilities
Medium impact · Low oddsFortive completed the Precision Technologies spin-off into Ralliant in 2025. The company warned that indemnification liabilities to Ralliant could hurt cash flow and results. This remains a lingering risk that could create surprise cash outlays.
Leadership transition distracts execution
Medium impact · Low oddsThe company continues to navigate CEO, CFO, and Chief People Officer transitions that began in 2025. Managing a newer post-spin structure while swapping out top executives introduces clear operational risk.
AI and cyber risks hit trusted workflows
Medium impact · Low oddsFortive incorporates artificial intelligence into products like predictive maintenance tools. The company warned of risks tied to accuracy, intellectual property, data privacy, and cybersecurity. These risks carry heavy consequences because customers use Fortive tools in safety-sensitive environments.
In one breath
What does Fortive do?
Fortive sells tools, software, and services for industrial and healthcare workflows. Its products help customers test equipment, manage assets, protect workers, sterilize instruments, and improve clinical productivity.
What happened to Fortive's Precision Technologies segment?
Fortive completed the spin-off of Precision Technologies into a new company called Ralliant on June 28, 2025. The remaining Fortive business focuses on Intelligent Operating Solutions and Advanced Healthcare Solutions.
Why did Fortive's Q2 2026 results matter?
Q2 showed an acceleration in growth, with core revenue rising 6.7%. The results proved that recent momentum was not a fluke, and management raised full-year guidance.
What is the main risk for Fortive right now?
The primary risk has shifted from tariffs to product mix. Fortive is selling more lower-margin products, which caused its adjusted gross margin to fall by about 100 basis points in the recent quarter.
